JC
GILD icon

JBF Capital’s Gilead Sciences GILD Stock Holding History

JBF Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,010
Closed -$71K – 64
2017
Q2 		$71K Hold
1,010
– – 0.01% 79
2017
Q1 		$69K Buy
+1,010
New +$71K 0.01% 78
2016
Q3 		– Sell
-26,000
Closed -$2.17M – 87
2016
Q2 		$2.17M Hold
26,000
– – 0.27% 23
2016
Q1 		$2.39M Buy
26,000
+16,000
+160% +$1.44M 0.3% 20
2015
Q4 		$1.01M Hold
10,000
– – 0.12% 33
2015
Q3 		$982K Buy
+10,000
New +$1.11M 0.13% 40
2014
Q3 		– Sell
-54,000
Closed -$4.48M – 63
2014
Q2 		$4.48M Buy
54,000
+7,100
+15% +$553K 0.66% 8
2014
Q1 		$3.32M Buy
+46,900
New +$3.68M 0.51% 11

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JBF Capital's GILD Position: Q3 2017 in Review

JBF Capital sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 1,010 shares — an estimated $71K sold.

JBF Capital first reported a position in GILD in Q1 2014 and held it in 8 quarters. The position peaked at $4.48M in Q2 2014. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • JBF Capital reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • JBF Capital sold 1,010 Gilead Sciences shares in Q3 2017, an estimated $71K.
  • JBF Capital first reported a position in Gilead Sciences in Q1 2014 and held it in 8 quarters.
  • JBF Capital's Gilead Sciences position peaked at $4.48M in Q2 2014.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on JBF Capital's 13F filing for Q3 2017, filed 13 Nov 2017.